A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)
- DOI
- 10.1093/cid/ciag196
- Published
- 2026-03-18
- Container
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/cid/ciag196,
title = {A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)},
author = {John R Koethe and Jordan E Lake and Amy Kantor and Laura Smeaton and Kristine Erlandson and Laura Moran and Pablo Belaunzaran-Zamudio and Alan Landay and Rafael E Campo and Paula Debroy and Jaclyn Ann Bennet and Jane O'Halloran and Win Min Han and Oladapo Alli and Michael Leonard and Roy M Gulick},
year = {2026},
journal = {Clinical Infectious Diseases},
doi = {10.1093/cid/ciag196},
url = {https://doi.org/10.1093/cid/ciag196}
}RIS
TY - JOUR TI - A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391) AU - John R Koethe AU - Jordan E Lake AU - Amy Kantor AU - Laura Smeaton AU - Kristine Erlandson AU - Laura Moran AU - Pablo Belaunzaran-Zamudio AU - Alan Landay AU - Rafael E Campo AU - Paula Debroy AU - Jaclyn Ann Bennet AU - Jane O'Halloran AU - Win Min Han AU - Oladapo Alli AU - Michael Leonard AU - Roy M Gulick PY - 2026 JO - Clinical Infectious Diseases DO - 10.1093/cid/ciag196 UR - https://doi.org/10.1093/cid/ciag196 ER -
APA
Koethe, J. R., Lake, J. E., Kantor, A., Smeaton, L., Erlandson, K., Moran, L., Belaunzaran-Zamudio, P., Landay, A., Campo, R. E., Debroy, P., Bennet, J. A., O'Halloran, J., Han, W. M., Alli, O., Leonard, M., & Gulick, R. M. (2026). A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag196
Source records
- crossref · retrieved 2026-09-25T09:09:00.717Z